אבקויר לאמיבודין תרו - Abacavir lamivudine taro
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | J05AR Antivirals for treatment of HIV infections, combinations | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||||||||||
| צ×רת ××ª× | פ××× - PER OS | |||||||||||||
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||||||||||
| ×ת×××× | ABACAVIR LAMIVUDINE TARO is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents and children weighing at least 25 kg. | |||||||||||||
| ||||||||||||||
| ×ת××ת ××× ×× | Posology and method of administration | |||||||||||||
| ×ת××××ת × ×× | Contraindications | |||||||||||||
| ת×פע×ת ××××× | Undesirable effects | |||||||||||||
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction | |||||||||||||
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation | |||||||||||||
| פר×ק×××× ×××§× | Pharmacodynamic Properties | |||||||||||||
| פר×ק×ק×× ×××§× | Pharmacokinetic Properties | |||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ××ק××ר ××××××××× ×ª×¨× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | REMEDICA LTD., CYPRUS |
| ×©× ××¢× ×ר×ש×× | TARO INTERNATIONAL LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 11/2017. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 16/09/2024 |
ת××× ×ª ×ר×××
השינוי האחרון נעשה בֹ־16 בספטמבר 2024 ב־12:58